Smoking increases the risk of extraintestinal manifestations in Crohn's disease
Authors:
Open Access
- 1 January 2014
- journal article
- Published by Baishideng Publishing Group Inc. in World Journal of Gastroenterology
- Vol. 20 (34) , 12269-76
Abstract
AIM: To demonstrate a high prevalence of extraintestinal manifestations (EIMs) in a prospective population-based cohort of inflammatory bowel disease (IBD) patients at first diagnosis as well as during the early course of the disease. METHODS: EIMs are common in patients with IBD. Data on the frequency of EIMs have mostly been assessed in patients from tertiary centers; however, data about the prevalence of EIMs at first diagnosis as well as factors influencing their incidence during the early course of disease from prospective population-based cohorts are scarce. We present data of patients of our population-based “Oberpfalz cohort” (Bavaria, Germany) from first diagnosis (up to 3 mo after first diagnosis) as well as during the early course of the disease. Possible risk factors were assessed by calculating the relative risk (RR) as well as using logistic regression analysis. RESULTS: In total, data of 257 newly diagnosed patients with IBD were evaluated [161 Crohn’s disease (CD), 96 ulcerative colitis (UC)]. Median duration of follow-up was 50 mo after first diagnosis. In 63.4% of all patients (n = 163), an EIM was diagnosed at any point during the observation period. At first diagnosis, patients with CD had a significantly increased risk of an EIM [n = 69 (42.9%)] compared with UC patients [n = 21 (21.9%); P < 0.001; RR = 1.96; 95%CI: 1.30-2.98]. Active smoking increased the risk of CD patients developing an EIM during the early course of the disease, but notably not of UC patients (P = 0.046; RR = 1.96; 95%CI: 1.01-3.79). In addition, using logistic regression analysis, the need for IBD-related surgery and a young age at first diagnosis were identified as risk factors for the development of an EIM in CD patients. No association with EIMs was found for the factors sex, localization of the disease and positive family history of IBD. In contrast, no key factors which increased the risk of development of an EIM could be identified in UC patients. CONCLUSION: We found a high prevalence of EIM in this cohort at first diagnosis and during the early course of the disease. In patients with CD, smoking, need for surgery and younger age at first diagnosis were risk factors for the development of an EIM.Keywords
This publication has 37 references indexed in Scilit:
- Adalimumab produces clinical remission and reduces extraintestinal manifestations in Crohnʼs disease: Results from CAREInflammatory Bowel Diseases, 2012
- Incidence and Risk of Intestinal and Extra-intestinal Complications in Medicaid Patients with Inflammatory Bowel Disease: A 5-Year Population-Based StudyDigestive Diseases and Sciences, 2010
- Inflammatory Bowel Disease in African American Children Compared With Other Racial/Ethnic Groups in a Multicenter RegistryClinical Gastroenterology and Hepatology, 2008
- The incidence of inflammatory bowel disease in a rural region of Southern Germany: a prospective population-based studyEuropean Journal of Gastroenterology & Hepatology, 2008
- Significance of Erythema Nodosum and Pyoderma Gangrenosum in Inflammatory Bowel DiseasesMedicine, 2008
- Extraintestinal Manifestations of Inflammatory Bowel DiseaseJournal of Pediatric Gastroenterology and Nutrition, 2008
- Relationship between clinical features of Crohn??s disease and the risk of developing extraintestinal manifestationsEuropean Journal of Gastroenterology & Hepatology, 2007
- Inflammatory bowel disease in Iran: A review of 457 casesJournal of Gastroenterology and Hepatology, 2005
- Cutaneous manifestations in inflammatory bowel disease*Zeitschrift für Gastroenterologie, 2001
- THE EXTRA-INTESTINAL COMPLICATIONS OF CROHNʼS DISEASE AND ULCERATIVE COLITIS: A STUDY OF 700 PATIENTSMedicine, 1976